Progenika Biopharma S.A., A Grifols Company

Progenika Biopharma S.A., A Grifols Company — FDA 510(k) Submissions

Progenika Biopharma S.A., A Grifols Company has submitted 4 FDA 510(k) premarket notifications since 2017, of which 4 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Serpina1 Variant Detection System, Genetic Variant Detection And Health Risk Assessment System . Use the specialty filter in the sidebar to narrow results.